Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion type Assertion NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_head.
- NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion description "[Further work is needed to identify optimal platforms for CAR-based adoptive immunotherapy for leukemia, to establish guidelines for managing toxicity, and to determine whether the remissions induced by this approach can be rendered durable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_provenance.
- NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion evidence source_evidence_literature NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_provenance.
- NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion SIO_000772 24319203 NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_provenance.
- NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion wasDerivedFrom befree-20150227 NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_provenance.
- NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_assertion wasGeneratedBy ECO_0000203 NP338532.RA-ZZ9BVAn8fVZdd1w9BUMDXvNmS-CoFBLjxUrCFIQvgY130_provenance.